Abstract | OBJECTIVE: The purpose of this study was to evaluate the risk of lung cancer surgery, following induction chemo and/or radiotherapy. METHODS: This retrospective study included 69 patients treated from January 1990 to January 1998 for a primary lung cancer in whom surgery had been performed after induction treatment. Surgery had not been considered initially for the following reasons: N2 disease (IIIA; n = 25), temporary functional impairment (2 stages IB and 2 stages IIIA [N2]; n = 4); doubtful resectability (stage IIIB [T4]; n = 40). The medical regimen resulted in combined radio- chemotherapy in 43 patients who received 2 to 4 cycles of chemotherapy (average = 2.9 +/- 0.8 cycles) and 43 +/- 8 Gy (20 to 60 Gy), or chemotherapy alone in 26 patients (3 +/- 0.7 cycles). RESULTS: CONCLUSION: Surgery for lung cancer after induction chemo and/or radiotherapy is associated with an increased risk. While the mortality seems "acceptable", the morbidity rate however is high.
|
Authors | C Doddoli, P Thomas, M Reynaud-Gaubert, R Giudicelli, L Papazian, P Fuentes |
Journal | Revue des maladies respiratoires
(Rev Mal Respir)
Vol. 17
Issue 6
Pg. 1081-7
(Dec 2000)
ISSN: 0761-8425 [Print] France |
Vernacular Title | Complications post opératoires après radiochimiothérapie ou chimiothérapie des cancers bronchiques. |
PMID | 11217503
(Publication Type: Journal Article)
|
Chemical References |
- Mitomycin
- Vinblastine
- Etoposide
- Cisplatin
- Vinorelbine
- Vindesine
- Fluorouracil
|
Topics |
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects)
- Bronchial Fistula
(etiology)
- Carcinoma, Bronchogenic
(mortality, therapy)
- Cause of Death
- Cisplatin
(administration & dosage)
- Etoposide
(administration & dosage)
- Female
- Fluorouracil
(administration & dosage)
- Hospital Mortality
- Humans
- Lung Neoplasms
(mortality, therapy)
- Male
- Middle Aged
- Mitomycin
(administration & dosage)
- Neoplasm Staging
- Pneumonectomy
(adverse effects)
- Pneumonia
(etiology)
- Radiotherapy, Adjuvant
(adverse effects)
- Reoperation
- Retrospective Studies
- Risk Factors
- Treatment Outcome
- Vinblastine
(administration & dosage, analogs & derivatives)
- Vindesine
(administration & dosage)
- Vinorelbine
|